| INFARMED [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Neurologique
> Sclérose en plaques | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 1 000 | National | Regularly | 115015053859 |
| We are partners in the Projeto Incluir [Inclusion Project] led by Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products]. | Cancer
> Cancer : sein | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 1 000 | Regional | Regularly | 115017018417 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Perte auditive
> Perte auditive | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 100 | National | No | 115029020137 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cérébrovasculaire
> Trait | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 5 000 | National | Regularly | 115032426383 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Défense des droits des patients
> Défense des droits des patients | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 5 000 | National | Rarely | 115033491291 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Santé mentale
> Santé mentale : la plupart des affections | Partenariat réglementaire
> Travailler avec les organismes de réglementation | 10 000 | National | Regularly | 115056273634 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Défense des droits des patients
> Défense des droits des patients | Partenariat réglementaire
> Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement | 5 000 | National | Rarely | 115033491291 |
| We occasionally receive a form through which we are invited to submit written contributions to HTA [Avaliação de Tecnologias de Saúde – Health Technology Assessment] processes. | Rhumatismal
> Maladies rhumatismales : la plupart des types | Partenariat réglementaire
> Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement | 100 | National | Sometimes | 115060632863 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurologique
> Sclérose en plaques | Partenariat réglementaire
> Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement | 5 000 | National | Regularly | 115060898897 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Défense des droits des patients
> Défense des droits des patients | Partenariat réglementaire
> Contribuer aux soumissions d'autorisation de mise sur le marché | 5 000 | National | Rarely | 115033491291 |
| We would, however, welcome a closer relationship with the regulatory authorities. We have already sought to engage with the European medicines regulatory body. | Perte auditive
> Perte auditive | Partenariat réglementaire
> Assister/faciliter des réunions avec des décideurs politiques/régulateurs | 100 | National | No | 115029020137 |
| Involvement in the Incluir project of Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products, Portugal], and participation on one occasion in the evaluation of a new medicine. [The Incluir project a strategic initiative designed to formalise and elevate the voice of patients and their representative associations in health-related decision-making and the lifecycle of medicines.] | Défense des droits des patients
> Défense des droits des patients | Partenariat réglementaire
> Assister/faciliter des réunions avec des décideurs politiques/régulateurs | 5 000 | National | Rarely | 115033491291 |
| We participate in the medicines evaluation process at the request of INFARMED [Instituto Nacional da Farmácia e do Medicamento – National Authority of Medicines and Health Products]. | Neurologique
> Sclérose en plaques | Partenariat réglementaire
> Assister/faciliter des réunions avec des décideurs politiques/régulateurs | 5 000 | National | Regularly | 115060898897 |
| Negotiation with the government or with parliamentary groups. | Santé générale
> Obésité | Influencer les politiques et la législation
> Influencer les politiques et la législation en matière de santé | 1 000 | National | Regularly | 115006675660 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratoire
> Asthme | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | Do not know | National | Sometimes | 115032964525 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratoire
> Asthme | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | Do not know | National | Sometimes | 115032964525 |
| 2023: meeting with the Parliamentary Health Group at the AR [Assembleia da República – Assembly of the Republic]. | Cardiovasculaire
> Maladies cardiovasculaires et cardiaques | Influencer les politiques et la législation
> Participer aux audiences publiques et aux consultations | 1 000 | National | Sometimes | 115054128784 |
| Negotiation with the government or with parliamentary groups. | Santé générale
> Obésité | Influencer les politiques et la législation
> Mobiliser les parlementaires et les dirigeants politiques | 1 000 | National | Regularly | 115006675660 |
| Each year, we submit our advocacy document to the parliamentary groups. | Handicap
> Handicap : la plupart des types | Influencer les politiques et la législation
> Mobiliser les parlementaires et les dirigeants politiques | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Through the Parliamentary Health Group. | Cardiovasculaire
> Maladies cardiovasculaires et cardiaques | Influencer les politiques et la législation
> Mobiliser les parlementaires et les dirigeants politiques | 100 | National | Regularly | 115033109950 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Handicap
> Handicap : la plupart des types | Plaidoyer pour la tarification et l'accessibilité financière
> Plaider pour une tarification équitable des médicaments | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Each year, we submit our advocacy memorandum to the parliamentary groups. This year's submission included a call for the free-of-charge provision of medicines and medical devices for persons with disabilities. | Handicap
> Handicap : la plupart des types | Plaidoyer pour la tarification et l'accessibilité financière
> Réduire les obstacles financiers pour les personnes à faibles revenus et les personnes vulnérables | We do not communicate with patients directly | National | Regularly | 115006736449 |
| Active participation in discussions on access to PAP [Programas de Acesso Precoce – Early Access Programmes] and in the centralised funding of medicines intended for rare diseases. | Neuromusculaire
> Maladies neuromusculaires : la plupart des types | Amélioration des voies d'accès
> Améliorer l'accès aux thérapies rares/ultra-rares | 1 000 | National | Regularly | 115022855373 |
| Questionnaire for the collection of contributions from patient associations in the context of Health Technology Assessment [in Portugal]. | Gastro-intestinal
> Gastro-intestinal : autre | Contribution des patients fondée sur des données probantes
> Mener des enquêtes/recherches pour générer des données | 1 000 | National | Sometimes | 114997613546 |
| Engagement activities have included hearings with parliamentary groups, open letters, press releases, and participation in the organisation of research studies. | Respiratoire
> Asthme | Contribution des patients fondée sur des données probantes
> Mener des enquêtes/recherches pour générer des données | Do not know | National | Sometimes | 115032964525 |
| Member of an Infarmed [Autoridade Nacional do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] panel. | Cérébrovasculaire
> Trait | Gouvernance institutionnelle
> Assurer la représentation au sein des organes consultatifs gouvernementaux | 5 000 | National | Regularly | 115032426383 |
| Projeto Incluir [The project establishes a formal mechanism for patient rights and civic participation in Portugal. It allows patients and their advocacy organizations to have an active voice in Health Technology Assessment (HTA), Medicine Shortages & Safety and Policy Representation: Acting as a bridge between policymakers and citizens, ensuring that healthcare decisions account for patient values and experiences.] | Défense des droits des patients
> Droits du patient | Gouvernance institutionnelle
> Assurer la représentation au sein des organes consultatifs gouvernementaux | 5 000 | National | Regularly | 115042989304 |
| FamiliarMente sits on the following advisory boards and committees: the National Council for Mental Health and the Regional Councils for Mental Health; the Infarmed [Instituto Nacional de Autoridade do Medicamento e Produtos de Saúde, I.P. – National Authority of Medicines and Health Products] Medicines Availability Management Monitoring Committee; and the Monitoring Committee for the Implementation of the Legal Framework for Involuntary Treatment (Mental Health Act), among others. | Santé mentale
> Santé mentale : la plupart des affections | Gouvernance institutionnelle
> Assurer la représentation au sein des organes consultatifs gouvernementaux | 10 000 | National | Regularly | 115056273634 |
| Through the Parliamentary Health Group. | Cardiovasculaire
> Maladies cardiovasculaires et cardiaques | Gouvernance institutionnelle
> Travailler efficacement au sein de réseaux multi-parties prenantes | 100 | National | Regularly | 115033109950 |
interactions
actions et plaidoyer
13 mentions
